These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21191429)

  • 41. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
    Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
    Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.
    Agus MS; Hirshberg E; Srinivasan V; Faustino EV; Luckett PM; Curley MA; Alexander J; Asaro LA; Coughlin-Wells K; Duva D; French J; Hasbani N; Sisko MT; Soto-Rivera CL; Steil G; Wypij D; Nadkarni VM
    Contemp Clin Trials; 2017 Feb; 53():178-187. PubMed ID: 28042054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycemic management in the inpatient setting.
    Schmeltz LR; Ferrise C
    Hosp Pract (1995); 2012 Apr; 40(2):44-55. PubMed ID: 22615078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of compliance with a paper-based, multiplication-factor, intravenous insulin protocol.
    Cyrus RM; Szumita PM; Greenwood BC; Pendergrass ML
    Ann Pharmacother; 2009 Sep; 43(9):1413-8. PubMed ID: 19654334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
    Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
    Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of hyperglycemia in acute illness: supporting evidence and its limitations.
    Corathers SD; Falciglia M
    Nutrition; 2011 Mar; 27(3):276-81. PubMed ID: 20869205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood glucose control in the intensive care unit: benefits and risks.
    Gunst J; Van den Berghe G
    Semin Dial; 2010; 23(2):157-62. PubMed ID: 20525106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of intensive insulin therapy in increasing superoxide dismutase (SOD) and normalizing hyperglycemia in critically ill patients.
    Wiryana M
    Acta Med Indones; 2009 Apr; 41(2):59-65. PubMed ID: 19390123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
    Rabinovich M; Grahl J; Durr E; Gayed R; Chester K; McFarland R; McLean B
    J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
    Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
    Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transition From Intravenous to Subcutaneous Insulin in Critically Ill Adults.
    Doolin MK; Walroth TA; Harris SA; Whitten JA; Fritschle-Hilliard AC
    J Diabetes Sci Technol; 2016 Jul; 10(4):932-8. PubMed ID: 26908569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose metabolism and insulin therapy.
    Langouche L; Van den Berghe G
    Crit Care Clin; 2006 Jan; 22(1):119-29, vii. PubMed ID: 16399023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?
    Egi M; Bellomo R; Reade MC
    Crit Care; 2009; 13(2):302. PubMed ID: 19435472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose and insulin administration while maintaining normoglycemia: the GIN concept.
    Carvalho G; Lattermann R; Codere-Maruyama T; Schricker T
    Minerva Anestesiol; 2013 Jan; 79(1):74-82. PubMed ID: 23032923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of glucose variability when converting from insulin infusion to basal-bolus regimen in a surgical-trauma intensive care unit.
    McKinzie BP; To L; Leon SM; Eriksson EA
    J Crit Care; 2013 Oct; 28(5):804-9. PubMed ID: 23876704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycemic control and insulin therapy in sepsis and critical illness.
    Garcia Branco R; Tasker RC; Ramos Garcia PC; Piva JP; Dias Xavier L
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S128-36. PubMed ID: 18038018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.
    Clayton SB; Mazur JE; Condren S; Hermayer KL; Strange C
    Crit Care Med; 2006 Dec; 34(12):2974-8. PubMed ID: 17075371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Humphrey LL; Chou R; Snow V; Shekelle P;
    Ann Intern Med; 2011 Feb; 154(4):260-7. PubMed ID: 21320941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A carbohydrate-restrictive strategy is safer and as efficient as intensive insulin therapy in critically ill patients.
    de Azevedo JR; de Araujo LO; da Silva WS; de Azevedo RP
    J Crit Care; 2010 Mar; 25(1):84-9. PubMed ID: 19327317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.